Citigroup Global Markets Limited Stabilisation Notice (0377J)

TIDMHIK

RNS Number : 0377J

Citigroup Global Markets Limited

31 March 2015

31(st) March 2015

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

Hikma Pharmaceuticals PLC

Stabilisation Notice

Citigroup Global Markets Limited. (contact: Syndicate Desk 0207 986 9000) hereby gives notice that the Stabilising Manager(s) named below may stabilise the offer of the following securities in accordance with Commission Regulation (EC) No. 2273/2003 implementing the Market Abuse Directive (2003/6/EC).

 
 The securities: 
------------------------------------------------------------- 
 Issuer:                     Hikma Pharmaceuticals PLC 
-------------------  ---------------------------------------- 
 Guarantor (if 
  any): 
-------------------  ---------------------------------------- 
 Aggregate nominal    $ TBC 
  amount: 
-------------------  ---------------------------------------- 
 Description:         Reg S registered 
-------------------  ---------------------------------------- 
 Offer price:         TBC 
-------------------  ---------------------------------------- 
 Other offer          TBC 
  terms 
-------------------  ---------------------------------------- 
 Stabilisation: 
------------------------------------------------------------- 
 Stabilising              Citigroup Global Markets Limited 
  Manager(s): 
-------------------  ---------------------------------------- 
 Stabilisation        1st April 2015 
  period expected 
  to start on: 
-------------------  ---------------------------------------- 
 Stabilisation        1st May 2015 (30 days after the 
  period expected      proposed issue date of the securities) 
  to end no later 
  than: 
-------------------  ---------------------------------------- 
 Maximum size         5% of the aggregate nominal amount 
  of over-allotment    stated above. 
  facility: 
-------------------  ----------------------------------------

In connection with the offer of the above securities, the Stabilising Manager(s) may over-allot the securities or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, there is no assurance that the Stabilising Manager(s) will take any stabilisation action and any stabilisation action, if begun, may be ended at any time.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

This announcement and the offer of the securities to which it relates are directed only at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

This information is provided by RNS

The company news service from the London Stock Exchange

END

STAJBMITMBTJBFA

Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024